New gene therapy targets brain disorders

November 9, 2017 by Wendy Van Zuijlen, University of New South Wales
New gene therapy developed with UNSW researchers targets brain disorders
Credit: Shutterstock

UNSW researchers have tailored gene therapy for a rare genetic disorder called Canavan disease, and say it could eventually be adapted to treat other inherited disorders affecting the brain.

A group of researchers led by UNSW Sydney has developed a new gene therapy that may reverse the devastating symptoms of disorders such as Canavan .

Canavan disease is a rare, fatal in which an enzyme called aspartoacylase is not active. This enzyme breaks down the amino acid NAA in the body.

In individuals with Canavan disease, NAA is not broken down and progressively damages the brain's white matter and its ability to support cellular communication in the nervous system. Over time, this damage causes symptoms such as lack of motor skills, weak muscle tone, developmental delay and seizures.

"In our previous study in rats with Canavan disease, we used gene therapy to restore aspartoacylase in called neurons, but the effects were very modest," said study leader Professor Matthias Klugmann from the Translational Neuroscience Facility in the School of Medical Sciences.

"This is when we reasoned that there must be a better cell type in the brain that we can target.

"Employing genetic engineering in mice, we found that other brain cells called oligodendrocytes are the only brain cells that normally make aspartoacylase, and that aspartoacylase in this cell type prevents brain damage by excess NAA. Therefore, we tailored the gene therapy around these cells.

"The basic technology that we used to deliver a normal copy of the aspartoacylase gene to neurons has been around for two decades. But we have now developed it to limit the activity of the therapeutic aspartoacylase gene to oligodendrocyte cells."

Lead author Dr Georg von Jonquieres, from the Translational Neuroscience Facility, said that in the study, the research team treated mice with symptoms of Canavan disease with the new gene therapy. When they took a magnetic resonance scan of the brains and tested their motor and behavioural skills, they found that the therapy reversed the disease symptoms.

Professor Klugmann said the researchers chose Canavan disease to test the but in the long-term, this technology could also be adapted to treat different leukodystrophies, which are inherited disorders whereby the brain's white matter is similarly affected.

The study was published in the journal Acta Neuropathologica.

Explore further: Team makes breakthrough in understanding Canavan disease

More information: Georg von Jonquieres et al. Uncoupling N-acetylaspartate from brain pathology: implications for Canavan disease gene therapy, Acta Neuropathologica (2017). DOI: 10.1007/s00401-017-1784-9

Related Stories

Team makes breakthrough in understanding Canavan disease

April 27, 2015
UC Davis investigators have settled a long-standing controversy surrounding the molecular basis of an inherited disorder that historically affected Ashkenazi Jews from Eastern Europe but now also arises in other populations ...

Gene immunotherapy protects against multiple sclerosis in mice

September 21, 2017
A potent and long-lasting gene immunotherapy approach prevents and reverses symptoms of multiple sclerosis in mice, according to a study published September 21st in the journal Molecular Therapy. Multiple sclerosis is an ...

Gene therapy cocktail shows promise in long-term clinical trial for rare fatal brain disorder

December 19, 2012
Results of a clinical trial that began in 2001 show that a gene therapy cocktail conveyed into the brain by a molecular special delivery vehicle may help extend the lives of children with Canavan disease, a rare and fatal ...

Gene therapy shows promise for treating Niemann-Pick disease type C1

October 26, 2016
For the first time, National Institutes of Health (NIH) researchers have demonstrated in mice that gene therapy may be the best method for correcting the single faulty gene that causes Niemann-Pick disease, type C1 (NPC1). ...

Conversion of brain cells offers hope for Parkinson's patients

April 11, 2017
Researchers at Karolinska Institutet have made significant progress in the search for new treatments for Parkinson's disease. By manipulating the gene expression of non-neuronal cells in the brain, they were able to produce ...

CD38 gene is identified to be important in postnatal development of the cerebral cortex

April 7, 2017
The brain consists of neurons and glial cells. The developmental abnormality of glial cells causes various diseases and aberrant cerebral cortex development. CD38 gene knockout is shown to cause aberrant development of glial ...

Recommended for you

Bursts of brain activity linked to memory reactivation

May 24, 2018
Leading theories propose that sleep presents an opportune time for important, new memories to become stabilized. And it's long been known which brain waves are produced during sleep. But in a new study, researchers set out ...

Study suggests brainwave link between disparate disorders

May 24, 2018
A brainwave abnormality could be a common link between Parkinson's disease, neuropathic pain, tinnitus and depression—a link that authors of a new study suggest could lead to treatment for all four conditions.

Researchers define molecular basis to explain link between a pregnant mother's nutrition and infant growth

May 24, 2018
For years, pregnant mothers have questioned their nutritional habits: "Will eating more cause my baby to be overweight?" Or, "I'm eating for two, so it won't hurt to have an extra serving, right?"

In a break with dogma, myelin boosts neuron growth in spinal cord injuries

May 23, 2018
Recovery after severe spinal cord injury is notoriously fraught, with permanent paralysis often the result. In recent years, researchers have increasingly turned to stem cell-based therapies as a potential method for repairing ...

Memory molecule limits plasticity by calibrating calcium

May 23, 2018
The brain has an incredible capacity to support a lifetime of learning and memory. Each new experience fundamentally alters the connections between cells in the brain called synapses. To accommodate synaptic alterations, ...

New type of vertigo identified

May 23, 2018
Neurologists have identified a new type of vertigo with no known cause, according to a study published in the May 23, 2018, online issue of Neurology, the medical journal of the American Academy of Neurology.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.